Literature DB >> 18759307

Treatment-failure gout: a moving target.

N Lawrence Edwards.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18759307     DOI: 10.1002/art.23803

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  19 in total

1.  Uricases as therapeutic agents to treat refractory gout: Current states and future directions.

Authors:  Xiaolan Yang; Yonghua Yuan; Chang-Guo Zhan; Fei Liao
Journal:  Drug Dev Res       Date:  2011-12-29       Impact factor: 4.360

2.  Quality of care in patients with gout: why is management suboptimal and what can be done about it?

Authors:  N Lawrence Edwards
Journal:  Curr Rheumatol Rep       Date:  2011-04       Impact factor: 4.592

Review 3.  Difficult-to-treat gouty arthritis: a disease warranting better management.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

Review 4.  Pegloticase: in treatment-refractory chronic gout.

Authors:  Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2011-11-12       Impact factor: 9.546

5.  Triuret as a potential hypokalemic agent: Structure characterization of triuret and triuret-alkali metal adducts by mass spectrometric techniques.

Authors:  Sergiu P Palii; Cesar S Contreras; Jeffrey D Steill; Stela S Palii; Jos Oomens; John R Eyler
Journal:  Arch Biochem Biophys       Date:  2010-04-03       Impact factor: 4.013

Review 6.  A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout.

Authors:  Jeannie Chao; Robert Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

Review 7.  Gout. Novel therapies for treatment of gout and hyperuricemia.

Authors:  Robert Terkeltaub
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

8.  The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.

Authors:  Michael A Becker; H Ralph Schumacher; Luis R Espinoza; Alvin F Wells; Patricia MacDonald; Eric Lloyd; Christopher Lademacher
Journal:  Arthritis Res Ther       Date:  2010-04-06       Impact factor: 5.156

Review 9.  Update on gout: new therapeutic strategies and options.

Authors:  Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

10.  The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study.

Authors:  R Terkeltaub; J S Sundy; H R Schumacher; F Murphy; S Bookbinder; S Biedermann; R Wu; S Mellis; A Radin
Journal:  Ann Rheum Dis       Date:  2009-07-26       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.